Details for New Drug Application (NDA): 062693
✉ Email this page to a colleague
NDA 062693 describes CEPHRADINE, which is a drug marketed by Barr, Ivax Sub Teva Pharms, Teva, and Vitarine, and is included in eight NDAs. Additional details are available on the CEPHRADINE profile page.
The generic ingredient in CEPHRADINE is cephradine. There are ten drug master file entries for this compound. Additional details are available on the cephradine profile page.
The generic ingredient in CEPHRADINE is cephradine. There are ten drug master file entries for this compound. Additional details are available on the cephradine profile page.
Summary for 062693
| Tradename: | CEPHRADINE |
| Applicant: | Teva |
| Ingredient: | cephradine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062693
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | 125MG/5ML | ||||
| Approval Date: | Jan 9, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | 250MG/5ML | ||||
| Approval Date: | Jan 9, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
